Cargando…
Revealing Calcium Signaling Pathway as Novel Mechanism of Danhong Injection for Treating Acute Myocardial Infarction by Systems Pharmacology and Experiment Validation
Introduction: Danhong injection (DHI) is a traditional Chinese medicine preparation commonly used in the clinical treatment of acute myocardial infarction (AMI). In this study, the active components of DHI and its mechanism in the treatment of AMI were investigated. Methods: The chemical components...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905633/ https://www.ncbi.nlm.nih.gov/pubmed/35281886 http://dx.doi.org/10.3389/fphar.2022.839936 |
_version_ | 1784665231635513344 |
---|---|
author | Guo, Siyu Tan, Yingying Huang, Zhihong Li, Yikui Liu, Weiyu Fan, Xiaotian Zhang, Jingyuan Stalin, Antony Fu, Changgeng Wu, Zhishan Wang, Penglong Zhou, Wei Liu, Xinkui Wu, Chao Jia, Shanshan Zhang, Jinyan Duan, Xiaoxia Wu, Jiarui |
author_facet | Guo, Siyu Tan, Yingying Huang, Zhihong Li, Yikui Liu, Weiyu Fan, Xiaotian Zhang, Jingyuan Stalin, Antony Fu, Changgeng Wu, Zhishan Wang, Penglong Zhou, Wei Liu, Xinkui Wu, Chao Jia, Shanshan Zhang, Jinyan Duan, Xiaoxia Wu, Jiarui |
author_sort | Guo, Siyu |
collection | PubMed |
description | Introduction: Danhong injection (DHI) is a traditional Chinese medicine preparation commonly used in the clinical treatment of acute myocardial infarction (AMI). In this study, the active components of DHI and its mechanism in the treatment of AMI were investigated. Methods: The chemical components of DHI were detected by the ultra-high-performance liquid chromatography-linear trap quadrupole-orbitrap-tandem mass spectrometry (UHPLC-LTQ-Orbitrap-MS/MS), and the targets and pathways of DHI in the treatment of AMI were analyzed by systems pharmacology, which was verified by molecular docking and animal experiments. Results: A total of 12 active components of DHI were obtained, and 158 common targets of component and disease were identified by systems pharmacology. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis results showed that DHI is closely related to the calcium signaling pathway in the treatment of AMI. Molecular docking showed that the key target protein has good binding affinity to related compounds. The experimental results showed that compared with the model group, LVAWs, EF, and FS significantly (p < 0.05) increased in the DHI group. The percentage of myocardial infarction significantly (p < 0.01) decreased, both in the ventricular and total cardiac regions, and the pathological damage of myocardial tissue also decreased. In addition, the expression of the protein CaMK II decreased (p < 0.01) and the expression of SERCA significantly increased (p < 0.01). Conclusion: This study revealed that ferulic acid, caffeic acid and rosmarinic acid could inhibit AMI by regulating PLB, CaMK II, SERCA, etc. And mechanistically, calcium signaling pathway was critically involved. Combination of systems pharmacology prediction with experimental validation may provide a scientific basis for in-depth clinical investigation of the material basis of DHI. |
format | Online Article Text |
id | pubmed-8905633 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89056332022-03-10 Revealing Calcium Signaling Pathway as Novel Mechanism of Danhong Injection for Treating Acute Myocardial Infarction by Systems Pharmacology and Experiment Validation Guo, Siyu Tan, Yingying Huang, Zhihong Li, Yikui Liu, Weiyu Fan, Xiaotian Zhang, Jingyuan Stalin, Antony Fu, Changgeng Wu, Zhishan Wang, Penglong Zhou, Wei Liu, Xinkui Wu, Chao Jia, Shanshan Zhang, Jinyan Duan, Xiaoxia Wu, Jiarui Front Pharmacol Pharmacology Introduction: Danhong injection (DHI) is a traditional Chinese medicine preparation commonly used in the clinical treatment of acute myocardial infarction (AMI). In this study, the active components of DHI and its mechanism in the treatment of AMI were investigated. Methods: The chemical components of DHI were detected by the ultra-high-performance liquid chromatography-linear trap quadrupole-orbitrap-tandem mass spectrometry (UHPLC-LTQ-Orbitrap-MS/MS), and the targets and pathways of DHI in the treatment of AMI were analyzed by systems pharmacology, which was verified by molecular docking and animal experiments. Results: A total of 12 active components of DHI were obtained, and 158 common targets of component and disease were identified by systems pharmacology. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis results showed that DHI is closely related to the calcium signaling pathway in the treatment of AMI. Molecular docking showed that the key target protein has good binding affinity to related compounds. The experimental results showed that compared with the model group, LVAWs, EF, and FS significantly (p < 0.05) increased in the DHI group. The percentage of myocardial infarction significantly (p < 0.01) decreased, both in the ventricular and total cardiac regions, and the pathological damage of myocardial tissue also decreased. In addition, the expression of the protein CaMK II decreased (p < 0.01) and the expression of SERCA significantly increased (p < 0.01). Conclusion: This study revealed that ferulic acid, caffeic acid and rosmarinic acid could inhibit AMI by regulating PLB, CaMK II, SERCA, etc. And mechanistically, calcium signaling pathway was critically involved. Combination of systems pharmacology prediction with experimental validation may provide a scientific basis for in-depth clinical investigation of the material basis of DHI. Frontiers Media S.A. 2022-02-23 /pmc/articles/PMC8905633/ /pubmed/35281886 http://dx.doi.org/10.3389/fphar.2022.839936 Text en Copyright © 2022 Guo, Tan, Huang, Li, Liu, Fan, Zhang, Stalin, Fu, Wu, Wang, Zhou, Liu, Wu, Jia, Zhang, Duan and Wu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Guo, Siyu Tan, Yingying Huang, Zhihong Li, Yikui Liu, Weiyu Fan, Xiaotian Zhang, Jingyuan Stalin, Antony Fu, Changgeng Wu, Zhishan Wang, Penglong Zhou, Wei Liu, Xinkui Wu, Chao Jia, Shanshan Zhang, Jinyan Duan, Xiaoxia Wu, Jiarui Revealing Calcium Signaling Pathway as Novel Mechanism of Danhong Injection for Treating Acute Myocardial Infarction by Systems Pharmacology and Experiment Validation |
title | Revealing Calcium Signaling Pathway as Novel Mechanism of Danhong Injection for Treating Acute Myocardial Infarction by Systems Pharmacology and Experiment Validation |
title_full | Revealing Calcium Signaling Pathway as Novel Mechanism of Danhong Injection for Treating Acute Myocardial Infarction by Systems Pharmacology and Experiment Validation |
title_fullStr | Revealing Calcium Signaling Pathway as Novel Mechanism of Danhong Injection for Treating Acute Myocardial Infarction by Systems Pharmacology and Experiment Validation |
title_full_unstemmed | Revealing Calcium Signaling Pathway as Novel Mechanism of Danhong Injection for Treating Acute Myocardial Infarction by Systems Pharmacology and Experiment Validation |
title_short | Revealing Calcium Signaling Pathway as Novel Mechanism of Danhong Injection for Treating Acute Myocardial Infarction by Systems Pharmacology and Experiment Validation |
title_sort | revealing calcium signaling pathway as novel mechanism of danhong injection for treating acute myocardial infarction by systems pharmacology and experiment validation |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905633/ https://www.ncbi.nlm.nih.gov/pubmed/35281886 http://dx.doi.org/10.3389/fphar.2022.839936 |
work_keys_str_mv | AT guosiyu revealingcalciumsignalingpathwayasnovelmechanismofdanhonginjectionfortreatingacutemyocardialinfarctionbysystemspharmacologyandexperimentvalidation AT tanyingying revealingcalciumsignalingpathwayasnovelmechanismofdanhonginjectionfortreatingacutemyocardialinfarctionbysystemspharmacologyandexperimentvalidation AT huangzhihong revealingcalciumsignalingpathwayasnovelmechanismofdanhonginjectionfortreatingacutemyocardialinfarctionbysystemspharmacologyandexperimentvalidation AT liyikui revealingcalciumsignalingpathwayasnovelmechanismofdanhonginjectionfortreatingacutemyocardialinfarctionbysystemspharmacologyandexperimentvalidation AT liuweiyu revealingcalciumsignalingpathwayasnovelmechanismofdanhonginjectionfortreatingacutemyocardialinfarctionbysystemspharmacologyandexperimentvalidation AT fanxiaotian revealingcalciumsignalingpathwayasnovelmechanismofdanhonginjectionfortreatingacutemyocardialinfarctionbysystemspharmacologyandexperimentvalidation AT zhangjingyuan revealingcalciumsignalingpathwayasnovelmechanismofdanhonginjectionfortreatingacutemyocardialinfarctionbysystemspharmacologyandexperimentvalidation AT stalinantony revealingcalciumsignalingpathwayasnovelmechanismofdanhonginjectionfortreatingacutemyocardialinfarctionbysystemspharmacologyandexperimentvalidation AT fuchanggeng revealingcalciumsignalingpathwayasnovelmechanismofdanhonginjectionfortreatingacutemyocardialinfarctionbysystemspharmacologyandexperimentvalidation AT wuzhishan revealingcalciumsignalingpathwayasnovelmechanismofdanhonginjectionfortreatingacutemyocardialinfarctionbysystemspharmacologyandexperimentvalidation AT wangpenglong revealingcalciumsignalingpathwayasnovelmechanismofdanhonginjectionfortreatingacutemyocardialinfarctionbysystemspharmacologyandexperimentvalidation AT zhouwei revealingcalciumsignalingpathwayasnovelmechanismofdanhonginjectionfortreatingacutemyocardialinfarctionbysystemspharmacologyandexperimentvalidation AT liuxinkui revealingcalciumsignalingpathwayasnovelmechanismofdanhonginjectionfortreatingacutemyocardialinfarctionbysystemspharmacologyandexperimentvalidation AT wuchao revealingcalciumsignalingpathwayasnovelmechanismofdanhonginjectionfortreatingacutemyocardialinfarctionbysystemspharmacologyandexperimentvalidation AT jiashanshan revealingcalciumsignalingpathwayasnovelmechanismofdanhonginjectionfortreatingacutemyocardialinfarctionbysystemspharmacologyandexperimentvalidation AT zhangjinyan revealingcalciumsignalingpathwayasnovelmechanismofdanhonginjectionfortreatingacutemyocardialinfarctionbysystemspharmacologyandexperimentvalidation AT duanxiaoxia revealingcalciumsignalingpathwayasnovelmechanismofdanhonginjectionfortreatingacutemyocardialinfarctionbysystemspharmacologyandexperimentvalidation AT wujiarui revealingcalciumsignalingpathwayasnovelmechanismofdanhonginjectionfortreatingacutemyocardialinfarctionbysystemspharmacologyandexperimentvalidation |